Differential induction of growth arrest inducible genes by selenium compounds

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 921-926

  Kaeck, Mark ^a   Lu, Junxuan ^a   Strange, Robert ^a   Ip, Clement ^b   Ganther, Howard E ^c   Thompson, Henry J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

gadd gene expression; mammary cells; p53; selenium

Indexed keywords

SELENIUM DERIVATIVE;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CELL; CANCER INHIBITION; CANCER PREVENTION; CELL DEATH; DOSE TIME EFFECT RELATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, DIFFERENTIATION; BLOTTING, NORTHERN; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL COUNT; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PROTEINS; RNA, MESSENGER; SELENIUM COMPOUNDS; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030950749     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00103-2     Document Type: Article

References (22)

1. Ip C, Hayes C, Budnick RM and Ganther HE, Chemical form of selenium, critical metabolites and cancer prevention. Cancer Res 51: 595-600, 1991.
2. Ip C and Ganther HE, Relationship between the chemical form of selenium and anticancer activity. In: Cancer Chemoprevention (Eds. Wattenberg LW, Lipkin M, Boone CW and Kelloff GJ), pp. 479-488. CRC Press, Boca Raton, FL, 1992.
3. Lu JX, Jiang C, Kaeck M, Ganther HE, Vadhanavikit S, Ip C and Thompson HJ, Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 50: 213-219, 1995.
4. Lu JX, Jiang C, Kaeck M, Ganther HE, Ip C and Thompson HJ, Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. Carcinogenesis 16: 513-517, 1995.
5. Thompson HJ, Wilson A, Lu JX, Singh M, Jiang C, Upadhyaya P, El-Bayoumy K and Ip C, Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15: 183-186, 1994.
6. Lu JX, Kaeck M, Jiang C, Wilson A and Thompson HJ, Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 47: 1531-1535, 1994.
7. Fornace AJ Jr, Alamo I Jr and Hollander MC, DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800-8804, 1988.
8. Luethy JD and Holbrook NJ, Activation of the gadd153 promoter by genotoxic agents: A rapid and specific response to DNA damage. Cancer Res 52: 5-10, 1992.
9. Zhan Q, Bae I, Kastan MB and Fornace AJ Jr, The p53-dependent γ-ray response of GADD45. Cancer Res 54: 2755-2760, 1994.
10. Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA and Fornace AJ Jr, The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14: 2361-2371, 1994.
11. Hollstein M, Sidransky D, Vogelstein B and Harris CC, p53 mutations in human cancers. Science 253: 49-53, 1991.
12. Vogelstein B and Kinzler KW, p53 function and dysfunction. Cell 70: 523-526, 1992.
13. Harris CC and Hollstein M, Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1327, 1993.
14. Harris CC, p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980-1981, 1993.
15. Greenblatt MS, Bennett WP, Hollstein M and Harris CC, Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
16. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE and Oltvai ZN, Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327-332, 1993.
17. Miyashita T, Harigai M, Hanada M and Reed JC, Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135, 1994.
18. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
19. Miyashita T and Reed JC, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
20. Ip C, El-Bayoumy K, Upadhyaya P, Ganther HE, Vadhanavikit S and Thompson HJ, Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer prevention. Carcinogenesis 15: 187-192, 1994.
21. Carbon SG, Fawcett TW, Bartlett JD, Bernier M and Holbrook NJ, Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol Cell Biol 13: 4736-4744, 1993.
22. Ron D and Habener JF, CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439-453, 1992.